期刊文献+

加替沙星和左氧氟沙星安全性的回顾性队列研究 被引量:3

Retrospective Cohort Study of Gatifloxacin and Levofloxacin Safety
下载PDF
导出
摘要 目的:对加替沙星和左氧氟沙星注射液的不良反应发生情况进行回顾性队列研究,重点观察两种药物给药前后患者血糖变化。方法:多中心,回顾性队列研究。结果:应用加替沙星和左氧氟沙星的患者均无严重不良反应记录;与左氧氟沙星相比,加替沙星致血糖升高,血糖降低,血糖紊乱的发生率显著增加(P<0.05)。结论:临床医生在应用加替沙星时应密切监控血糖的变化。 Objective: To investigate the adverse drug reaction (ADR) of gatifloxacin and levofloxacin through the retrospective cohort study, and especially observe the fluctuation of blood glucose befere the medication. Method: A multi-center and retrospective cohort study was carried out. Result: Neither gatifloxacin nor levofloxacin caused any serious ADR, but the percentage of hyperglycemia and hypoglycemia in gatifloxacin was higher than that of levofloxacin. Conclusion: The blood glucose level should be monitored careflully when using gatifloxacin.
出处 《药物流行病学杂志》 CAS 2009年第2期82-84,共3页 Chinese Journal of Pharmacoepidemiology
基金 国家食品药品监督管理局安全监管司课题组成部分。
关键词 加替沙星 左氧氟沙星 队列研究 回顾性 药物不良反应 血糖 Gatifloxacin Levofloxacin Retrospective cohort study ADR Blood glucose
  • 相关文献

参考文献5

  • 1雷波.了解和防范加替沙星的不良反应/事件[N].健康报,2005-11-23.005版.
  • 2Laura Y, David N, Kopp A, et al. Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults [ J]. N Engl J Med, 2006,354(13) : 1352-1361.
  • 3Shu-Chean C, Wong FA, Cynthia L,et al. Double-Blind E- valuation of the Safety and Pharmacokinetics of Multiple Oral Once-Daily 750-Milligram and 1-Gram Doses of Levofloxacin in Healthy Volunteers[ J]. Anti Agents Chem, 1998,42(4) : 885 -888.
  • 4侯芳,郑波,薛峰,李家泰.加替沙星与左氧氟沙星随机对照治疗急性细菌性感染安全性评价[J].药物流行病学杂志,2004,13(6):306-308. 被引量:2
  • 5Paul G, Sujata M, Brenda B, et al. Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction [ J ]. J Anti Chem, 2003,52 : 435-440.

二级参考文献2

  • 1Naber KG, Hollauer K, Kirchbauer D, et al. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections[J]. Int
  • 2Gajjar DA, LaCreta FP, Uderman HD, et al. A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men[J]. Pharmacotherapy, 2000,20(6 Pt 2):49S-58S

共引文献1

同被引文献50

引证文献3

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部